Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability

June 27, 2024 8:15 AM

REDWOOD CITY, CA / ACCESSWIRE / June 27, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its financial results for the fourth quarter and fiscal year ended March 31, 2024.Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, "Fiscal 2024 has been a year of massive transformation for Biotricity. We...

Read more

NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments

June 27, 2024 8:00 AM

NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, today announced preclinical results from multiple in vitro studies targeting alpha-synuclein (α-synuclein), specifically the A53T mutation, that demonstrate the compounds' potential to advance the treatment of Parkinson's Disease...

Read more

FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia

June 27, 2024 7:30 AM

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces that it has received approval by the human ethics review committee (HREC) in Australia for its trial entitled "A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate...

Read more

RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting

June 27, 2024 7:00 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today. All but one of the proposed resolutions were approved by a large majority of the represented votes. AGM...

Read more

Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform

June 27, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / June 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, today announced the commercial launch of its second equine focused assay - Cortisol for equine serum - for the point-of-care TRUFORMA® diagnostic platform."Cortisol measurement is crucial for assessing the health of sick foals and...

Read more

Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts

June 27, 2024 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to report advancements in its pre-clinical programs.Genflow has initiated a feasibility study with a Contract Development Manufacturing Organization (CDMO), Exothera S.A, to assess the ability to produce its future MASH...

Read more

EY Announces Dr. Jin Kim of Rezolut as an Entrepreneur of the Year(R) 2024 Southeast Award Winner

June 26, 2024 6:15 PM

Celebrating the bold leaders who disrupt markets, revolutionize industries and transform livesATLANTA, GA / ACCESSWIRE / June 26, 2024 / Ernst & Young LLP (EY US) recently announced that CEO Dr. Jin Kim of Rezolut was named an Entrepreneur of The Year® 2024 Southeast Award winner. Entrepreneur of The Year is the preeminent competitive awards program for entrepreneurs and leaders of high-growth companies. Rezolut Logo Company logo Dr. Jin Kim,...

Read more

Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27

June 26, 2024 4:15 PM

REDWOOD CITY, CA / ACCESSWIRE / June 26, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, announced that it will host its fourth quarter and fiscal year 2024 financial results and business update call on Thursday, June 27, 2024. Biotricity Founder and CEO Dr. Waqaas Al-Siddiq and CFO John Ayanoglou will deliver...

Read more

Vogenx Announces Positive Results From Second Phase 2 Study of Mizagliflozin in Post-Bariatric Hypoglycemia

June 26, 2024 3:00 PM

DURHAM, NC / ACCESSWIRE / June 26, 2024 / Vogenx, a clinical-stage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases, today announced positive results from study VGX 001-012 evaluating Mizagliflozin in patients diagnosed with post-bariatric hypoglycemia (PBH).Mizagliflozin is an investigational first-in-class, oral, small molecule drug candidate that reduces postprandial glucose absorption and...

Read more

More Than Just Money

June 26, 2024 11:45 AM

NORTHAMPTON, MA / ACCESSWIRE / June 26, 2024 / CARE "There is no specific role for a man, there is no specific role for a woman, and there is no role for children. We all divide the work and we do it willingly. We help each other. It has created cooperation. I am empowered because, after the training, I can now express myself. I speak freely and my husband and children listen to me. I can even go to [savings group] meetings and chair the...

Read more

New Study Finds ZetrOZ Systems’ Sustained Acoustic Medicine Technology Effectively Treats Chronic Low Back Pain

June 26, 2024 10:45 AM

Study shows treatment with low-intensity, continuous ultrasound reduced patients' pain and need for pain medication. TRUMBULL, CT / ACCESSWIRE / June 26, 2024 / Nearly one out of four Americans (23.3%) suffer from chronic low back pain. A new study finds that low-intensity continuous ultrasound, such as ZetrOZ Systems' sustained acoustic medicine (sam®) technology, alleviates the symptoms of chronic lower back pain and reduces the need for pain...

Read more

Mann Eye Institute Unveils State-of-the-Art Office-Based Surgery Center in Austin

June 26, 2024 9:00 AM

AUSTIN, TX / ACCESSWIRE / June 26, 2024 / Mann Eye Institute announces the grand opening of its office-based surgery center, Mann Austin Surgery Center, at 4314 W. Braker Lane, Suite #215, Austin, TX 78759. This innovative facility, within the newly remodeled Austin North Clinic, marks a significant advancement in ophthalmic care for Austin. The Mann Austin Surgery Center introduces a revolutionary approach to eye surgeries by bringing advanced...

Read more

KindlyMD Announces Successful SAM.gov Registration and Grant Application

June 26, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce its successful registration on SAM.gov, the official U.S. federal funding platform. The System for Award Management (SAM.gov) is a U.S. government website that provides contractors...

Read more

Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement

June 26, 2024 8:30 AM

SAN FRANCISCO, CA / ACCESSWIRE / June 26, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on June 25, 2024 the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that Jaguar has regained compliance with Nasdaq's minimum bid price requirement."We are very happy that Jaguar has regained compliance with Nasdaq. We consider our Nasdaq listing an asset of the Company," said Lisa Conte,...

Read more

CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

June 26, 2024 8:00 AM

HOUSTON, TX / ACCESSWIRE / June 26, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it has entered into securities purchase agreements with health-care focused institutional investors for the purchase and sale of 568,000 shares of common stock in a...

Read more

AMSBIO and Bioz Combine Efforts to Empower the Scientific Community With Citation Data

June 26, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / June 26, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is delighted to combine efforts with AMSBIO, a global life sciences supplier focused on providing high-quality reagents and services to support scientists and researchers in various fields, including cell biology, stem cell research, neuroscience, and cancer research. Bioz Prime Badge Bioz Prime Badge on the AMSBIO Website To empower the...

Read more

Berlin Cures Announces Changes to Board of Directors to Further Propel the Development of BC 007

June 26, 2024 2:20 AM

Berlin Cures, a pioneer in the use of aptamer-based therapeutics in autoimmune diseases, announced important changes to its Board of Directors today. The aim is to further drive the development of the company's lead drug candidate BC 007, currently in a Phase II clinical trial for Long COVID. Berlin Cures welcomes three distinguished new members who bring a wealth of knowledge and strategic insight to its board of directors:Craig T. Basson , MD,...

Read more

Empowering Latino Leaders: LCF Georgia's Second Civic Participation Fellowship Program

June 25, 2024 2:00 PM

LCF Georgia's Civic Participation Fellowship Program: 21 Fellows Trained in Civic Engagement and Community OrganizingATLANTA, GA / ACCESSWIRE / June 25, 2024 / Over the past weekend, the Latino Community Fund (LCF Georgia) successfully concluded its second Civic Participation Fellowship Program, a transformative three-day in-person initiative aimed at empowering Latino youth and community members across Georgia. The program provided invaluable...

Read more

Horizon Treatment Services Ushers in a New Era of Inclusion With Drop-in Center for LGBTQIA+ Youth

June 25, 2024 12:00 PM

Safe Haven for Youth and Young AdultsHAYWARD, CA / ACCESSWIRE / June 25, 2024 / City and community unite for the ribbon-cutting ceremony on August 9, reflecting the commitment to diversity, equity, and the mental health support of young people.Project Eden's Lambda Drop-In Center will open Summer 2024 Project Eden, a program of Horizon Treatment Services, finds yet another way to serve the youth of Alameda County. The Project Eden Lambda Youth...

Read more

PMD Device Solutions Increases Financial Target with 160% to 260m SEK by YE 2026

June 25, 2024 11:45 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / June 25, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) today announced it has revised its annual recurring revenue (ARR) target from 100m SEK to 260m SEK by yearend 2026. The increase is driven by the current strong business activity in the UK and the acquisition and subsequent restructuring of the US remote patient monitoring company.New 2026 ARR target of 260m SEKReaffirming cash...

Read more